Roth Capital analyst Chris Lewis today maintained a Buy rating on Nanosphere, Inc. (NSPH), with a price target of $3.
In a research note issued today, Roth Capital analyst Chris Lewis reiterated a Buy rating and boosted his price target on EnteroMedics Inc. (ETRM) to $5.
In a research note issued this morning, Roth Capital analyst Chris Lewis reiterated coverage with a “Buy” rating on LeMaitre Vascular, Inc. (LMAT), and a price target of …
In a research note issued today, Roth Capital reiterated coverage with a “Buy” rating on EnteroMedics Inc. (ETRM), and a price target of $3.
